Results 1-137 of 137 (Search time: 0.025 seconds).
Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link | |
---|---|---|---|---|---|---|---|
1 | 2024 | Secretome from Magnetically Stimulated Muscle Exhibits Anticancer Potency: Novel Preconditioning Methodology Highlighting HTRA1 Action | Tai, Yee Kit; Iversen, Jan Nikolas; Chan, Karen Ka Wing; Fong, Charlene Hui Hua; Abdul Razar, Rafhanah Banu; Ramanan, Sharanya; Yap, Lye Yee Jasmine; Yin, Jocelyn Naixin; Toh, Shi Jie; Wong, Craig Jun Kit; Koh, Pei Fern Angele; RUBY YUN-JU HUANG ; Franco-Obregón, Alfredo | Cells | |||
2 | 2023 | Author Correction: The effect of inhibition of receptor tyrosine kinase AXL on DNA damage response in ovarian cancer | Yeo, Xun Hui; Sundararajan, Vignesh; Wu, Zhengwei; Phua, Zi Jin Cheryl; Ho, Yin Ying; Peh, Kai Lay Esther; Chiu, Yi-Chia; Tan, Tuan Zea; Kappei, Dennis; Ho, Ying Swan; Tan, David Shao Peng; Tam, Wai Leong; RUBY YUN-JU HUANG | Communications biology | 0 | 0 | |
3 | 2023 | The effect of inhibition of receptor tyrosine kinase AXL on DNA damage response in ovarian cancer | Yeo, Xun Hui; Sundararajan, Vignesh; Wu, Zhengwei; Phua, Zi Jin Cheryl; Ho, Yin Ying; Peh, Kai Lay Esther; Chiu, Yi-Chia; Tan, Tuan Zea; Kappei, Dennis; Ho, Ying Swan; Tan, David Shao Peng; Tam, Wai Leong; RUBY YUN-JU HUANG | Communications biology | 4 | 1 | |
4 | 2023 | Immune-Hot tumor features associated with recurrence in early-stage ovarian clear cell carcinoma | RUBY YUN-JU HUANG ; KUAN-JU HUANG ; Chen, Ko-Chen; Hsiao, Sheng-Mou; Tan, Tuan Zea; CHIN-JUI WU ; Hsu, Ching; WEN-CHUN CHANG ; Pan, Chen-Yu; BOR-CHING SHEU ; LIN-HUNG WEI | International journal of cancer | 3 | 2 | |
5 | 2023 | Nodal reactive proliferation of monocytoid B-cells may represent atypical memory B-cells | SHAN-CHI YU ; Chen, Ko-Chen; RUBY YUN-JU HUANG | Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi | 0 | 0 | |
6 | 2023 | The CAM Model—Q&A with Experts | Fischer, Dagmar; Fluegen, Georg; Garcia, Paul; Ghaffari-Tabrizi-Wizsy, Nassim; Gribaldo, Laura; RUBY YUN-JU HUANG ; Rasche, Volker; Ribatti, Domenico; Rousset, Xavier; Pinto, Marta Texeira; Viallet, Jean; Wang, Yan; Schneider-Stock, Regine | Cancers | 18 | ||
7 | 2022 | 3D genome organization in the epithelial-mesenchymal transition spectrum | Pang, Qing You; Tan, Tuan Zea; Sundararajan, Vignesh; Chiu, Yi Chia; Chee, Edward Yu Wing; Chung, Vin Yee; Choolani, Mahesh A.; RUBY YUN-JU HUANG | Genome Biology | 10 | 10 | |
8 | 2022 | Genome-wide association study of primary dysmenorrhea in the Taiwan Biobank validates associations near the NGF and IL1 gene loci | CHIEN-CHANG LEE ; Lee, Meng-Tse Gabriel; Huang, I-Hsuan; Tan, Jasmine; McCaw, Zachary R; Su, Ke-Ying; Hsu, Tzu-Chun; Huang, Ruby Yun-Ju ; PO-HSIU KUO ; SHYR-CHYR CHEN | Journal of Human Genetics | 0 | 0 | |
9 | 2022 | Corrigendum: Modulated TRPC1 Expression Predicts Sensitivity of Breast Cancer to Doxorubicin and Magnetic Field Therapy: Segue Towards a Precision Medicine Approach(Front. Oncol., (2022), 11, (783803), 10.3389/fonc.2021.783803) | Tai, Yee Kit; Chan, Karen Ka Wing; Fong, Charlene Hui Hua; Ramanan, Sharanya; Yap, Jasmine Lye Yee; Yin, Jocelyn Naixin; Yip, Yun Sheng; Tan, Wei Ren; Koh, Angele Pei Fern; Tan, Nguan Soon; Chan, Ching Wan; RUBY YUN-JU HUANG ; Li, Jing Ze; Fröhlich, Jürg; Franco-Obregón, Alfredo | Frontiers in Oncology | 0 | 0 | |
10 | 2022 | Weekly versus tri-weekly paclitaxel with carboplatin for first-line treatment in women with epithelial ovarian cancer | Ngoi, Natalie Y.L.; Syn, Nicholas L.X.; Goh, Robby M.; Goh, Boon Cher; RUBY YUN-JU HUANG ; Soon, Yu Yang; James, Elizabeth; Cook, Adrian; Clamp, Andrew; Tan, David S.P. | Cochrane Database of Systematic Reviews | 8 | 6 | |
11 | 2022 | Modulated TRPC1 Expression Predicts Sensitivity of Breast Cancer to Doxorubicin and Magnetic Field Therapy: Segue Towards a Precision Medicine Approach | Tai, Yee Kit; Chan, Karen Ka Wing; Fong, Charlene Hui Hua; Ramanan, Sharanya; Yap, Jasmine Lye Yee; Yin, Jocelyn Naixin; Yip, Yun Sheng; Tan, Wei Ren; Koh, Angele Pei Fern; Tan, Nguan Soon; Chan, Ching Wan; RUBY YUN-JU HUANG ; Li, Jing Ze; Fröhlich, Jürg; Franco-Obregón, Alfredo | Frontiers in Oncology | 11 | 9 | |
12 | 2022 | Applications of the Chick Chorioallantoic Membrane as an Alternative Model for Cancer Studies | Chu P.-Y.; Koh A.P.-F.; Antony J.; RUBY YUN-JU HUANG | Cells Tissues Organs | 34 | 32 | |
13 | 2021 | Epigenetic derepression converts PPARγ into a druggable target in triple-negative and endocrine-resistant breast cancers | Loo, Ser Yue; Syn, Nicholas L.; Koh, Angele Pei Fern; Teng, Janet Cheng Fei; Deivasigamani, Amudha; Tan, Tuan Zea; Thike, Aye Aye; Vali, Shireen; Kapoor, Shweta; Wang, Xiaoyuan; Wang, Jiong Wei; Tan, Puay Hoon; Yip, George W.; Sethi, Gautam; RUBY YUN-JU HUANG ; Hui, Kam Man; Wang, Lingzhi; Goh, Boon Cher; Kumar, Alan Prem | Cell Death Discovery | 6 | 6 | |
14 | 2021 | Author Correction: Guidelines and definitions for research on epithelial-mesenchymal transition | Yang, Jing; Antin, Parker; Berx, Geert; Blanpain, Cédric; Brabletz, Thomas; Bronner, Marianne; Campbell, Kyra; Cano, Amparo; Casanova, Jordi; Christofori, Gerhard; Dedhar, Shoukat; Derynck, Rik; Ford, Heide L; Fuxe, Jonas; García de Herreros, Antonio; Goodall, Gregory J; Hadjantonakis, Anna-Katerina; RUBY YUN-JU HUANG ; Kalcheim, Chaya; Kalluri, Raghu; Kang, Yibin; Khew-Goodall, Yeesim; Levine, Herbert; Liu, Jinsong; Longmore, Gregory D; Mani, Sendurai A; Massagué, Joan; Mayor, Roberto; McClay, David; Mostov, Keith E; Newgreen, Donald F; Nieto, M Angela; Puisieux, Alain; Runyan, Raymond; Savagner, Pierre; Stanger, Ben; Stemmler, Marc P; Takahashi, Yoshiko; Takeichi, Masatoshi; Theveneau, Eric; Thiery, Jean Paul; Thompson, Erik W; Weinberg, Robert A; Williams, Elizabeth D; Xing, Jianhua; Zhou, Binhua P; Sheng, Guojun | Nature reviews. Molecular cell biology | 12 | 13 | |
15 | 2021 | A multi-ethnic analysis of immune-related gene expression signatures in patients with ovarian clear cell carcinoma | Heong, Valerie; Tan, Tuan Z.; Miwa, Maiko; Ye, Jieru; Lim, Diana; Herrington, C. Simon; Iida, Yasushi; Yano, Mitsutake; Yasuda, Masanori; Ngoi, Natalie Y.L.; Wong, SB Justin; Okamoto, Aikou; Gourley, Charlie; Hasegawa, Kosei; Tan, David S.P.; RUBY YUN-JU HUANG | Journal of Pathology | 5 | 5 | |
16 | 2021 | High prevalence of APOA1/C3/A4/A5 alterations in luminal breast cancers among young women in East Asia | LIN, CHING-HUNG ; RUBY YUN-JU HUANG ; TZU-PIN LU ; KUAN-TING KUO ; Lo, Ko-Yun; Chen, Ching-Hsuan; I-CHUN CHEN ; YEN-SHEN LU ; ERIC YAO-YU CHUANG ; Thiery, Jean Paul; CHIUN-SHENG HUANG ; ANN-LII CHENG | NPJ breast cancer | 4 | 4 | |
17 | 2021 | A reasoned approach towards administering COVID-19 vaccines to pregnant women | Pramanick, Angsumita; Kanneganti, Abhiram; Wong, Jing Lin Jeslyn; Li, Sarah Weiling; Dimri, Pooja Sharma; Mahyuddin, Aniza Puteri; Kumar, Sailesh; Illanes, Sebastian Enrique; Chan, Jerry Kok Yen; Su, Lin Lin; Biswas, Arijit; Tambyah, Paul Anantharajah; RUBY YUN-JU HUANG ; Mattar, Citra Nurfarah Zaini; Choolani, Mahesh | Prenatal Diagnosis | 7 | 6 | |
18 | 2021 | Evolution of CP2 transcription factors in Hexapoda | MATAN SHELOMI ; Tan T.Z; Huang R.Y.-J. | Journal of Genetics | 1 | 1 | |
19 | 2021 | Prognostic significance of phosphoglycerate dehydrogenase in breast cancer | Chandrika M.; Chua P.J.; Muniasamy U.; RUBY YUN-JU HUANG ; Thike A.A.; Ng C.T.; Tan P.H.; Yip G.W.; Bay B.H. | Breast Cancer Research and Treatment | 10 | 6 | |
20 | 2021 | High-throughput functional profiling of single adherent cellsviahydrogel drop-screen | Wang M.; Nai M.H.; RUBY YUN-JU HUANG ; Leo H.L.; Lim C.T.; Chen C.-H. | Lab on a Chip | 16 | 12 | |
21 | 2021 | Putting the BRK on breast cancer: From molecular target to therapeutics | Ang H.L.; Yuan Y.; Lai X.; Tan T.Z.; Wang L.; Huang B.B.; Pandey V.; RUBY YUN-JU HUANG ; Lobie P.E.; Goh B.C.; Sethi G.; Yap C.T.; Chan C.W.; Lee S.C.; Kumar A.P. | Theranostics | 15 | 14 | |
22 | 2020 | Correction: Sundararajan, V., et al. SNAI1-Driven Sequential EMT Changes Attributed by Selective Chromatin Enrichment of RAD21 and GRHL2. Cancers 2020, 12, 1140 | Sundararajan, Vignesh; Tan, Ming; Tan, Tuan Zea; Pang, Qing You; Ye, Jieru; Chung, Vin Yee; RUBY YUN-JU HUANG | Cancers | 0 | 0 | |
23 | 2020 | Mechanisms and evidence of vertical transmission of infections in pregnancy including SARS-CoV-2 | Mahyuddin, A P; Kanneganti, A; Wong, Jlj; Dimri, P Sharma; Su, L L; Biswas, A; Illanes, S E; Mattar, Cnz; RUBY YUN-JU HUANG ; Choolani, M | Prenatal diagnosis | 55 | 47 | |
24 | 2020 | Guidelines and definitions for research on epithelial-mesenchymal transition | Yang, Jing; Antin, Parker; Berx, Geert; Blanpain, Cédric; Brabletz, Thomas; Bronner, Marianne; Campbell, Kyra; Cano, Amparo; Casanova, Jordi; Christofori, Gerhard; Dedhar, Shoukat; Derynck, Rik; Ford, Heide L; Fuxe, Jonas; García de Herreros, Antonio; Goodall, Gregory J; Hadjantonakis, Anna-Katerina; RUBY YUN-JU HUANG ; Kalcheim, Chaya; Kalluri, Raghu; Kang, Yibin; Khew-Goodall, Yeesim; Levine, Herbert; Liu, Jinsong; Longmore, Gregory D; Mani, Sendurai A; Massagué, Joan; Mayor, Roberto; McClay, David; Mostov, Keith E; Newgreen, Donald F; Nieto, M Angela; Puisieux, Alain; Runyan, Raymond; Savagner, Pierre; Stanger, Ben; Stemmler, Marc P; Takahashi, Yoshiko; Takeichi, Masatoshi; Theveneau, Eric; Thiery, Jean Paul; Thompson, Erik W; Weinberg, Robert A; Williams, Elizabeth D; Xing, Jianhua; Zhou, Binhua P; Sheng, Guojun | Nature reviews. Molecular cell biology | 1071 | 845 | |
25 | 2020 | Cysteine Deprivation Targets Ovarian Clear Cell Carcinoma Via Oxidative Stress and Iron-Sulfur Cluster Biogenesis Deficit | Novera, Wisna; Lee, Zheng-Wei; Nin, Dawn Sijin; Dai, Melvin Zi-Yu; Binte Idres, Shabana; Wu, Hui; Damen, Mirjam A; Tan, Tuan Zea; Sim, Arthur Yi Loong; Long, Yun Chau; Wu, Wei; RUBY YUN-JU HUANG ; Deng, Lih-Wen | Antioxidants & redox signaling | 20 | 21 | |
26 | 2020 | Spotlight on the Granules (Grainyhead-Like Proteins) – From an Evolutionary Conserved Controller of Epithelial Trait to Pioneering the Chromatin Landscape | Sundararajan V.; Pang Q.Y.; Choolani M.; RUBY YUN-JU HUANG | Frontiers in Molecular Biosciences | 10 | 9 | |
27 | 2020 | A Method to sort heterogenous cell populations based on migration in 2D and 3D environments | Arora, Aditya; Niño, Jorge Luis Galeano; Myaing, Myint Zu; Arasi, Bakya; RUBY YUN-JU HUANG ; Dasgupta, Ramanuj; Biro, Maté; Viasnoff, Virgile | bioRxiv | 0 | 0 | |
28 | 2020 | Two high-yield complementary methods to sort cell populations by their 2D or 3D migration speed | Arora A.; Ni?o J.L.G.; Myaing M.Z.; Chia S.; Arasi B.; Ravasio A.; RUBY YUN-JU HUANG ; Dasgupta R.; Biro M.; Viasnoff V. | Molecular Biology of the Cell | 1 | 1 | |
29 | 2020 | Pharmacological Inhibition of BAD Ser99 Phosphorylation Enhances the Efficacy of Cisplatin in Ovarian Cancer by Inhibition of Cancer Stem Cell-like Behavior | Wang Y.; Chiou Y.-S.; Chong Q.-Y.; Zhang M.; Rangappa K.S.; Ma L.; Zhu T.; Kumar A.P.; RUBY YUN-JU HUANG ; Pandey V.; Basappa, Lobie P.E. | ACS Pharmacology and Translational Science | 5 | 6 | |
30 | 2020 | Snai1-driven sequential emt changes attributed by selective chromatin enrichment of RAD21 and GRHL2 | Sundararajan V.; Tan M.; Tan T.Z.; Pang Q.Y.; Ye J.; Chung V.Y.; RUBY YUN-JU HUANG | Cancers | 10 | 11 | |
31 | 2020 | Development and validation of the gene expression predictor of high-grade serous ovarian carcinoma molecular SubTYPE (PrOTYPE) | Talhouk A.; George J.; Wang C.; Budden T.; Tan T.Z.; Chiu D.S.; Kommoss S.; Leong H.S.; Chen S.; Intermaggio M.P.; Gilks B.; Nazeran T.M.; Volchek M.; Elatre W.; Bentley R.C.; Senz J.; Lum A.; Chow V.; Sudderuddin H.; Mackenzie R.; Leong S.C.Y.; Liu G.; Johnson D.; Chen B.; Alsop J.; Banerjee S.N.; Behrens S.; Bodelon C.; Brand A.H.; Brinton L.; Carney M.E.; Chiew Y.-E.; Cushing-Haugen K.L.; Cybulski C.; Ennis D.; Fereday S.; Fortner R.T.; Garc?a-Donas J.; Gentry-Maharaj A.; Glasspool R.; Goranova T.; Greene C.S.; Haluska P.; Harris H.R.; Hendley J.; Hernandez B.Y.; Herpel E.; Jimenez-Linan M.; Karpinskyj C.; Kaufmann S.H.; Keeney G.L.; Kennedy C.J.; Kobel M.; Koziak J.M.; Larson M.C.; Lester J.; Lewsley L.-A.; Lissowska J.; Lubi?ski J.; Luk H.; Macintyre G.; Mahner S.; McNeish I.A.; Menkiszak J.; Nevins N.; Osorio A.; Oszurek O.; Palacios J.; Hinsley S.; Pearce C.L.; Pike M.C.; Piskorz A.M.; Ray-Coquard I.; Rhenius V.; Rodriguez-Antona C.; Sharma R.; Sherman M.E.; de Silva D.; Singh N.; Sinn P.; Slamon D.; Song H.; Steed H.; Stronach E.A.; Thompson P.J.; To?oczko A.; Trabert B.; Traficante N.; Tseng C.-C.; Widschwendter M.; Wilkens L.R.; Winham S.J.; Winterhoff B.; Beeghly-Fadiel A.; Benitez J.; Berchuck A.; Brenton J.D.; Brown R.; Chang-Claude J.; Chenevix-Trench G.; deFazio A.; Fasching P.A.; Garc?a M.J.; Gayther S.A.; Goodman M.T.; Gronwald J.; Henderson M.J.; Karlan B.Y.; Kelemen L.E.; Menon U.; Orsulic S.; Pharoah P.D.P.; Wentzensen N.; Wu A.H.; Schildkraut J.M.; Rossing M.A.; Konecny G.E.; Huntsman D.G.; RUBY YUN-JU HUANG ; Goode E.L.; Ramus S.J.; Doherty J.A.; Bowtell D.D.; Anglesio M.S.; AOCS Group | Clinical Cancer Research | 37 | 33 | |
32 | 2020 | Activation of STAT3 and STAT5 signaling in epithelial ovarian cancer progression: Mechanism and therapeutic opportunity | CHIN-JUI WU ; Sundararajan V.; BOR-CHING SHEU ; RUBY YUN-JU HUANG ; LING-HUNG WEI | Cancers | 48 | 37 | |
33 | 2020 | Stopping transformed cancer cell growth by rigidity sensing | Yang B.; Wolfenson H.; Chung V.Y.; Nakazawa N.; Liu S.; Hu J.; RUBY YUN-JU HUANG ; Sheetz M.P. | Nature Materials | 68 | 61 | |
34 | 2020 | Inflammatory and mitogenic signals drive interleukin 23 subunit alpha (IL23A) secretion independent of IL12B in intestinal epithelial cells | Lim K.S.; Ern Yong Z.W.; Wang H.; Tan T.Z.; RUBY YUN-JU HUANG ; Yamamoto D.; Inaki N.; Hazawa M.; Wong R.W.; Oshima H.; Oshima M.; Ito Y.; Chih-Cheng Voon X.D. | Journal of Biological Chemistry | 19 | 18 | |
35 | 2020 | Erratum: Author Correction: Single-cell analysis of EphA clustering phenotypes to probe cancer cell heterogeneity (Communications biology (2020) 3 1 (429)) | Ravasio A.; Myaing M.Z.; Chia S.; Arora A.; Sathe A.; Cao E.Y.; Bertocchi C.; Sharma A.; Arasi B.; Chung V.Y.; Greene A.C.; Tan T.Z.; Chen Z.; Ong H.T.; Iyer N.G.; RUBY YUN-JU HUANG ; DasGupta R.; Groves J.T.; Viasnoff V. | Communications biology | 0 | 1 | |
36 | 2020 | Single-cell analysis of EphA clustering phenotypes to probe cancer cell heterogeneity | Ravasio A.; Myaing M.Z.; Chia S.; Arora A.; Sathe A.; Cao E.Y.; Bertocchi C.; Sharma A.; Arasi B.; Chung V.Y.; Green A.C.; Tan T.Z.; Chen Z.; Ong H.T.; Iyer N.G.; RUBY YUN-JU HUANG ; DasGupta R.; Groves J.T.; Viasnoff V. | Communications Biology | 3 | 4 | |
37 | 2020 | Identification of serum cytokine clusters associated with outcomes in ovarian clear cell carcinoma | Yabuno A.; Matsushita H.; Hamano T.; Tan T.Z.; Shintani D.; Fujieda N.; Tan D.S.P.; RUBY YUN-JU HUANG ; Fujiwara K.; Kakimi K.; Hasegawa K. | Scientific Reports | 4 | 3 | |
38 | 2020 | Effect of inhibition of receptor tyrosine kinase AXL by a selective small molecular inhibitor R428 (BGB321) on DNA damage repair response in ovarian cancer cells | RUBY YUN-JU HUANG ; Yeo, Xun Hui; Tam, Wai Leong | Journal of Clinical Oncology | 0 | 0 | |
39 | 2020 | Functional reservoir microcapsules generated: via microfluidic fabrication for long-term cardiovascular therapeutics | Dinh N.-D.; Kukumberg M.; Nguyen A.-T.; Keramati H.; Guo S.; Phan D.-T.; Ja'afar N.B.; Birgersson E.; Leo H.L.; RUBY YUN-JU HUANG ; Kofidis T.; Rufaihah A.J.; Chen C.-H. | Lab on a Chip | 28 | 23 | |
40 | 2020 | RNA-binding protein ZFP36L1 suppresses hypoxia and cell-cycle signaling | Loh X.-Y.; Sun Q.-Y.; Ding L.-W.; Mayakonda A.; Venkatachalam N.; Yeo M.-S.; Silva T.C.; Xiao J.-F.; Doan N.B.; Said J.W.; Ran X.-B.; Zhou S.-Q.; Dakle P.; Shyamsunder P.; Koh A.P.-F.; RUBY YUN-JU HUANG ; Berman B.P.; Tan S.-Y.; Yang H.; Lin D.-C.; Phillip Koeffler H. | Cancer Research | 35 | 28 | |
41 | 2020 | Cytoskeletal proteins in cancer and intracellular stress: A therapeutic perspective | Ong M.S.; Deng S.; Halim C.E.; Cai W.; Tan T.Z.; RUBY YUN-JU HUANG ; Sethi G.; Hooi S.C.; Kumar A.P.; Yap C.T. | Cancers | 57 | 54 | |
42 | 2019 | Reply to Pontus Eriksson and Gottfrid Sjödahl's Letter to the Editor re: Tuan Zea Tan, Mathieu Rouanne, Kien Thiam Tan, Ruby Yun-Ju Huang, Jean-Paul Thiery. Molecular Subtypes of Urothelial Bladder Cancer: Results from a Meta-cohort Analysis of 2411 Tumors. Eur Urol 2019;75:423-32 | Tan, Tuan Zea; Rouanne, Mathieu; RUBY YUN-JU HUANG ; Thiery, Jean-Paul | European urology | 3 | 0 | |
43 | 2019 | The role of GRHL2 and epigenetic remodeling in epithelial–mesenchymal plasticity in ovarian cancer cells | Chung V.Y.; Tan T.Z.; Ye J.; Huang, R.-L.; Lai H.-C.; Kappei D.; Wollmann H.; Guccione E.; RUBY YUN-JU HUANG | Communications Biology | 51 | 48 | |
44 | 2019 | Epithelial-to-mesenchymal transition: Lessons from development, insights into cancer and the potential of EMT-subtype based therapeutic intervention | Antony J.; Thiery J.P.; RUBY YUN-JU HUANG | Physical Biology | 47 | 40 | |
45 | 2019 | Molecular Subtypes of Urothelial Bladder Cancer: Results from a Meta-cohort Analysis of 2411 Tumors | Tan T.Z.; Rouanne M.; Tan K.T.; RUBY YUN-JU HUANG ; Thiery J.-P. | European Urology | 185 | 168 | |
46 | 2019 | Quantitative imaging and characterization of collagen patterns in high grade serous ovarian carcinoma (HGSOC) | RUBY YUN-JU HUANG ; Tan, T.Z.; Ye, J.; Lim, D.; Tan, D.S. | Annals of Oncology | 0 | 0 | |
47 | 2019 | 2010P Quantitative imaging and characterization of collagen patterns in high grade serous ovarian carcinoma (HGSOC) | RUBY YUN-JU HUANG ; Tan, T. Z.; Ye, J.; Lim, D.; Tan, D. S. | Annals of Oncology | |||
48 | 2019 | SNAI1 recruits HDAC1 to suppress SNAI2 transcription during epithelial to mesenchymal transition | Sundararajan V.; Tan M.; Tan T.Z.; Ye J.; Thiery J.P.; RUBY YUN-JU HUANG | Scientific Reports | 30 | 29 | |
49 | 2019 | Asian society of gynecologic oncology international workshop 2018 | Kong T.-W.; Ryu H.-S.; Kim S.C.; Enomoto T.; Li J.; Kim K.H.; Shim S.-H.; Wang P.-H.; Therasakvichya S.; Kobayashi Y.; Lee M.; Shi T.; Lee S.-W.; Mikami M.; Nagase S.; Lim M.C.; Wang J.; Wilailak S.; Kim S.W.; Hong S.-H.; Tan D.S.P.; Mandai M.; Chang S.-J.; RUBY YUN-JU HUANG ; Ushijima K.; Lee J.-Y.; Chen X.; Ochiai K.; Lee T.S.; Yang B.; Kalam F.; Lv Q.; Ahmad M.F.; Yaznil M.R.; Modi K.B.; Manopunya M.; Jeong D.H.; Lertkhachonsuk A.-A.; Chung H.H.; Watari H.; Jeon S. | Journal of Gynecologic Oncology | 7 | 7 | |
50 | 2019 | The FZD7-TWIST1 axis is responsible for anoikis resistance and tumorigenesis in ovarian carcinoma | Tan M.; Asad M.; Heong V.; Wong M.K.; Tan T.Z.; Ye J.; Kuay K.T.; Thiery J.P.; Scott C.; RUBY YUN-JU HUANG | Molecular Oncology | 17 | 14 | |
51 | 2019 | Actin cytoskeleton self-organization in single epithelial cells and fibroblasts under isotropic confinement | Jalal S.; Shi S.; Acharya V.; RUBY YUN-JU HUANG ; Viasnoff V.; Bershadsky A.D.; Tee Y.H. | Journal of Cell Science | 37 | 32 | |
52 | 2019 | Decoding transcriptomic intra-tumour heterogeneity to guide personalised medicine in ovarian cancer | Tan T.Z.; Heong V.; Ye J.; Lim D.; Low J.; Choolani M.; Scott C.; Tan D.S.P.; RUBY YUN-JU HUANG | Journal of Pathology | 14 | 12 | |
53 | 2019 | Reply to Pontus Eriksson and Gottfrid Sj?dahl's Letter to the Editor re: Tuan Zea Tan, Mathieu Rouanne, Kien Thiam Tan, Ruby Yun-Ju Huang, Jean-Paul Thiery. Molecular Subtypes of Urothelial Bladder Cancer: Results from a Meta-cohort Analysis of 2411 Tumors. Eur Urol 2019;75:423–32 | Tan T.Z.; Rouanne M.; RUBY YUN-JU HUANG ; Thiery J.-P. | European Urology | 3 | 0 | |
54 | 2019 | Analysis of gene expression signatures identifies prognostic and functionally distinct ovarian clear cell carcinoma subtypes | Tan T.Z.; Ye J.; Yee C.V.; Lim D.; Ngoi N.Y.L.; Tan D.S.P.; RUBY YUN-JU HUANG | EBioMedicine | 40 | 39 | |
55 | 2019 | Immune-related gene expression signatures (irGES) in patients (pts) with ovarian clear cell carcinomas (OCCC): A multicenter analysis | Heong, V.; Tan, T.Z.; Ye, J.; Miwa, M.; Lim, D.; Herrington, C.S.; Iida, Y.; Okamoto, A.; Low, J.; Ng, J.; Lim, S.E.; Lim, Y.W.; Gourley, C.; Hasegawa, K.; Tan, D.S.; RUBY YUN-JU HUANG | Annals of Oncology | 0 | 0 | |
56 | 2018 | Gene Expression Signatures in Ovarian Clear Cell Carcinomas and Potential Therapeutic Implications | V Heong; TZ Tan; J Ye; DG Lim; YW Lim; SE Lim; J Ng; J Low; A Ilancheran; RUBY YUN-JU HUANG | International Journal of Gynecological Cancer | |||
57 | 2018 | Phase 2 Study of IV Vinorelbine in Relapsed Platinum Resistant/Refractory C5 High Grade Serous, Endometrioid or Undifferentiated Primary Peritoneum, Fallopian Tube or Ovarian Cancer | V Heong; J Ye; G Au Yeung; TZ Tan; D Bowtell; RUBY YUN-JU HUANG ; M Linda; D Tan | Journal of Gynecological Cancer | |||
58 | 2018 | Thymoquinone Inhibits Bone Metastasis of Breast Cancer Cells Through Abrogation of the CXCR4 Signaling Axis | Shanmugam, Muthu K; Ahn, Kwang Seok; Hsu, Annie; Woo, Chern Chiuh; Yuan, Yi; Tan, Kwong Huat Benny; Chinnathambi, Arunachalam; Alahmadi, Tahani Awad; Alharbi, Sulaiman Ali; Koh, Angele Pei Fern; Arfuso, Frank; RUBY YUN-JU HUANG ; Lim, Lina H K; Sethi, Gautam; Kumar, Alan Prem | Frontiers in pharmacology | 130 | 121 | |
59 | 2018 | The tumour suppressor OPCML promotes AXL inactivation by the phosphatase PTPRG in ovarian cancer | Antony J.; Zanini E.; Kelly Z.; Tan T.Z.; Karali E.; Alomary M.; Jung Y.; Nixon K.; Cunnea P.; Fotopoulou C.; Paterson A.; Roy-Nawathe S.; Mills G.B.; RUBY YUN-JU HUANG ; Thiery J.P.; Gabra H.; Recchi C. | EMBO Reports | 26 | 29 | |
60 | 2018 | Dual role of autophagy in hallmarks of cancer | Singh S.S.; Vats S.; Chia A.Y.-Q.; Tan T.Z.; Deng S.; Ong M.S.; Arfuso F.; Yap C.T.; Goh B.C.; Sethi G.; RUBY YUN-JU HUANG ; Shen H.M.; Manjithaya R.; Kumar A.P. | Oncogene | 389 | 354 | |
61 | 2018 | Long Non-coding RNA Landscape in Colorectal Cancer | Ong, M. S.; Cai, W.; Tan, T. Z.; RUBY YUN-JU HUANG ; Hooi, S. C.; Yap, C. T.; Kumar, A. P. | RNA & DISEASE | 0 | 0 | |
62 | 2018 | BRK”ing” Down All We Know About PTK6 in Breast Cancer | Yuan, Yi; Ang, Hui Li; Lai, Xianning; Wang, Lingzhi; Pandey, Vijay; Huang, Benjamin BoJun; Tan, Tuan Zea; Chong, Hui Yi; Ong, Philip Zheng Yang; Rangappa, Kanchugarakoppal S.; Arfuso, Frank; Tan, Kevin Shyong-Wei; Basappa, null; Goh, Boon Cher; RUBY YUN-JU HUANG ; Sethi, Gautam; Lobie, Peter E.; Kumar, Alan Prem | 0 | 0 | ||
63 | 2018 | Integrated molecular analysis of Asian ovarian cancer: Gene expression and whole exome sequencing analyses from the iPocc Translational Research study (TriPocc) | RUBY YUN-JU HUANG ; Tan, TZ; Ye, J; Kuschal, C; Mok, ZY; Goh, SE; Tan, SL; Tay, JX; Omar, MFM; Sato, S; Jeyasekharan, AD; Lim, D; Soong, RCT; Fujiwara, K; Hasegawa, K; Tan, DSP | JOURNAL OF CLINICAL ONCOLOGY | 1 | ||
64 | 2018 | Patient stratification and determining clinical outcome for cancer patients | Thiery, J. P.; RUBY YUN-JU HUANG ; Chua, K. N.; Sim, W. J.; Mori, S. | ||||
65 | 2017 | ALDH-high signature enriched ovarian clear cell carcinoma correlates with advanced disease, poor patient outcomes, and unique immune profiles | RUBY YUN-JU HUANG ; Tuan Zea Tan; Jieru Ye; Kuee Theng Kuay; Diana GZ Lim; Jeffrey JH Low; Mahesh Choolani; David SP Tan | ||||
66 | 2017 | Hypoxia-inducible factor-1α promotes cell survival during ammonia stress response in ovarian cancer stem-like cells | Kitajima S.; Lee K.L.; Hikasa H.; Sun W.; RUBY YUN-JU HUANG ; Yang H.; Matsunaga S.; Yamaguchi T.; Araki M.; Kato H.; Poellinger L. | Oncotarget | 29 | 20 | |
67 | 2017 | Intracellular hyper-acidification potentiated by hydrogen sulfide mediates invasive and therapy resistant cancer cell death | Lee Z.-W.; Teo X.-Y.; Song Z.J.; Nin D.S.; Novera W.; Choo B.A.; Dymock B.W.; Moore P.K.; RUBY YUN-JU HUANG ; Deng L.-W. | Frontiers in Pharmacology | 24 | 23 | |
68 | 2017 | AXL-driven EMT state as a targetable conduit in cancer | Antony J.; RUBY YUN-JU HUANG | Cancer Research | 127 | 120 | |
69 | 2017 | Prognostic relevance of immune-related gene expression signatures (irGES) in patients (pts) with ovarian clear cell carcinomas (OCCC) | Heong, V.; Lim, D.; Tan, T.Z.; Ye, J.; Lim, Y.W.; Lim, S.E.; Ng, J.; Ilancheran, A.; Loh, J.; Soong, R.; SP. Tan, D.; RUBY YUN-JU HUANG | Annals of Oncology | 0 | 0 | |
70 | 2017 | Targeting the AXL signaling pathway in ovarian cancer | RUBY YUN-JU HUANG ; Antony J.; Tan T.Z.; Tan D.S.-P. | Molecular and Cellular Oncology | 13 | 0 | |
71 | 2017 | Synergistic lethality of mAbs with an EMT reversal agent, Nintedanib, in epithelial ovarian cancer | Teo, J; Tan, HL; RUBY YUN-JU HUANG ; Choo, A | CANCER RESEARCH | 0 | 0 | |
72 | 2017 | The phosphatase PTPRG inactivates AXL? sequestered in membrane lipid domains by the tumor suppressor OPCML | Antony, J.; Zanini, E.; Kelly, Z.; RUBY YUN-JU HUANG ; Thiery, J.; Gabra, H.; Recchi, C. | Molecular Biology of The Cell | |||
73 | 2017 | KDM4B under hypoxia: A new targetable pathway for epithelial ovarian cancer? | Chung V.Y.; RUBY YUN-JU HUANG | Translational Cancer Research | 0 | 0 | |
74 | 2017 | Molecular characterization of a panel of ovarian clear cell carcinoma (OCCC) cell lines | RUBY YUN-JU HUANG ; Ye, J.; Kuay, K.T.; Tan, T.Z.; Heong, V.; Tan, D.S. | Annals of Oncology | 0 | 0 | |
75 | 2017 | ‘Lnc’-ing Wnt in female reproductive cancers: therapeutic potential of long non-coding RNAs in Wnt signalling | Ong M.S.; Cai W.; Yuan Y.; Leong H.C.; Tan T.Z.; Mohammad A.; You M.L.; Arfuso F.; Goh B.C.; Warrier S.; Sethi G.; Tolwinski N.S.; Lobie P.E.; Yap C.T.; Hooi S.C.; RUBY YUN-JU HUANG ; Kumar A.P. | British Journal of Pharmacology | 57 | 56 | |
76 | 2017 | Loss of discoidin domain receptor 1 (DDR1) via CpG methylation during EMT in epithelial ovarian cancer | Chung V.Y.; Tan T.Z.; Huang, R.-L.; Lai H.-C.; RUBY YUN-JU HUANG | Gene | 19 | 16 | |
77 | 2017 | The EMT spectrum and therapeutic opportunities | Voon D.C.; RUBY YUN-JU HUANG ; Jackson R.A.; Thiery J.P. | Molecular Oncology | 75 | 71 | |
78 | 2016 | Frizzled-7 (FZD7)-mediated non-canonical Wnt-Planar Cell Polarity (PCP) signalling pathway as a novel molecular driver for the C5/Proliferative/Stem-A molecular subtype of ovarian cancer | Asad, M; Wong, MK; Tan, TZ; Virshup, D; Thiery, JP; RUBY YUN-JU HUANG | CLINICAL CANCER RESEARCH | 0 | ||
79 | 2016 | Warburg metabolism in tumor-conditioned macrophages promotes metastasis in human pancreatic ductal adenocarcinoma | Penny H.L.; Sieow J.L.; Adriani G.; Yeap W.H.; See Chi Ee P.; San Luis B.; Lee B.; Lee T.; Mak S.Y.; Ho Y.S.; Lam K.P.; Ong C.K.; RUBY YUN-JU HUANG ; Ginhoux F.; Rotzschke O.; Kamm R.D.; Wong S.C. | OncoImmunology | 161 | 161 | |
80 | 2016 | 297O Stratifying ovarian cancer based on AXL signaling for therapeutic targeting | RUBY YUN-JU HUANG ; Antony, J.; Tan, T.Z.; Low, J.; Choolani, M.; Thiery, J.P. | Annals of Oncology | 0 | 0 | |
81 | 2016 | Comparisons of genetic alterations of breast cancer between East and West: Special emphases on young patients with ER /HER2tumors | CHIU-HSUN LIN; Lu, TP; RUBY YUN-JU HUANG ; Lu, YS; Lo, KY; Kuo, KT; Chuang, EY; Wu, PF; Chen, IC; Thiery, JP; Huang, CS; Cheng, AL | CANCER RESEARCH | 0 | 0 | |
82 | 2016 | Sustained Gas6/AXL signaling network in the mes subtype of ovarian cancer as a molecular subtype specific therapeutic target | RUBY YUN-JU HUANG ; Antony, J.; Tan, T. Z.; Kelly, Z.; Gabra, H.; Recchi, C.; Thiery, J. P. | Journal of Clinical Oncology | |||
83 | 2016 | A COL11A1-correlated pan-cancer gene signature of activated fibroblasts for the prioritization of therapeutic targets | Jia D.; Liu Z.; Deng N.; Tan T.Z.; RUBY YUN-JU HUANG ; Taylor-Harding B.; Cheon D.-J.; Lawrenson K.; Wiedemeyer W.R.; Walts A.E.; Karlan B.Y.; Orsulic S. | Cancer Letters | 83 | 76 | |
84 | 2016 | A new dimension in drug discovery: Reversing epithelial–mesenchymal transition (EMT) | RUBY YUN-JU HUANG ; Huang T.Y.-Y. | Cell Death and Disease | 6 | 4 | |
85 | 2016 | The GAS6-AXL signaling network is a mesenchymal (Mes) molecular subtype-specific therapeutic target for ovarian cancer | Antony J.; Tan T.Z.; Kelly Z.; Low J.; Choolani M.; Recchi C.; Gabra H.; Thiery J.P.; RUBY YUN-JU HUANG | Science Signaling | 91 | 91 | |
86 | 2016 | GRHL2-miR-200-ZEB1 maintains the epithelial status of ovarian cancer through transcriptional regulation and histone modification | Chung V.Y.; Tan T.Z.; Tan M.; Wong M.K.; Kuay K.T.; Yang Z.; Ye J.; Muller J.; Koh C.M.; Guccione E.; Thiery J.P.; RUBY YUN-JU HUANG | Scientific Reports | 114 | 106 | |
87 | 2016 | An epithelial marker promoter induction screen identifies histone deacetylase inhibitors to restore epithelial differentiation and abolishes anchorage independence growth in cancers | Tang, H M; Kuay, K T; Koh, P F; Asad, M; Tan, T Z; Chung, V Y; Lee, S C; Thiery, J P; RUBY YUN-JU HUANG | Cell death discovery | 32 | 34 | |
88 | 2016 | EMT: 2016 | Nieto M.A.; RUBY YUN-JU HUANG ; Jackson R.A.; Thiery J.P. | Cell | 3267 | 2994 | |
89 | 2015 | The receptor tyrosine kinase AXL modulates oncogenic signaling and epithelial mesenchymal transition in epithelial ovarian cancer | Antony, J; Tan, TZ; Paterson, A; Recchi, C; Gabra, H; Thiery, JP; RUBY YUN-JU HUANG | CLINICAL CANCER RESEARCH | 0 | 0 | |
90 | 2015 | Quantitate epithelial-mesenchymal transition in ovarian cancer | Tan, TZ; RUBY YUN-JU HUANG ; Miow, QH; Ye, JR; Wong, MK; Lau, JA; Mori, S; Thiery, JP | CLINICAL CANCER RESEARCH | 0 | 0 | |
91 | 2015 | Epithelial-mesenchymal transition driven by transcriptional feedback loops contributes to intertumoral molecular heterogeneity in the metastasis and relapse of epithelial ovarian cancer | Chung, VY; Tan, M; Tan, TZ; Kuay, KT; Ye, J; Thiery, JP; RUBY YUN-JU HUANG | CLINICAL CANCER RESEARCH | 0 | 0 | |
92 | 2015 | Transcriptional regulatory loops among SNAI1, TWIST1, ZEB1, and ZEB2 defines the epithelial-mesenchymal transition (EMT) spectrum in epithelial ovarian cancer (EOC) | Tan, M; Chuang, VY; Tan, TZ; Thiery, JP; RUBY YUN-JU HUANG | CANCER RESEARCH | 0 | 0 | |
93 | 2015 | CSIOVDB: A microarray gene expression database of epithelial ovarian cancer subtype | Tan T.Z.; Yang H.; Ye J.; Low J.; Choolani M.; Peng Tan D.S.; Thiery J.-P.; RUBY YUN-JU HUANG | Oncotarget | 64 | 59 | |
94 | 2015 | LNK (SH2B3): Paradoxical effects in ovarian cancer | Ding L.-W.; Sun Q.-Y.; Lin D.-C.; Chien W.; Hattori N.; Dong X.-M.; Gery S.; Garg M.; Doan N.B.; Said J.W.; Xiao J.-F.; Yang H.; Liu L.-Z.; Meng X.; RUBY YUN-JU HUANG ; Tang K.; Koeffler H.P. | Oncogene | 19 | 17 | |
95 | 2015 | The clinical role of epithelial-mesenchymal transition and stem cell markers in advanced-stage ovarian serous carcinoma effusions | Davidson B.; Holth A.; Hellesylt E.; Tan T.Z.; RUBY YUN-JU HUANG ; Trop? C.; Nesland J.M.; Thiery J.P. | Human Pathology | 49 | 45 | |
96 | 2015 | Functional relevance of a six mesenchymal gene signature in epithelial-mesenchymal transition (EMT) reversal by the triple angiokinase inhibitor, nintedanib (BIBF1120) | RUBY YUN-JU HUANG ; Kuay K.T.; Tan T.Z.; Asad M.; Tang H.M.; Chun Ng A.H.; Ye J.; Chung V.Y.; Thiery J.P. | Oncotarget | 40 | 38 | |
97 | 2014 | FZD7 drives in vitro aggressiveness in Stem-A subtype of ovarian cancer via regulation of non-canonical Wnt/PCP pathway | Asad, M; Wong, M K; Tan, T Z; Choolani, M; Low, J; Mori, S; Virshup, D; Thiery, J P; RUBY YUN-JU HUANG | Cell death & disease | 91 | 88 | |
98 | 2014 | Rapid prototyping of concave microwells for the formation of 3D multicellular cancer aggregates for drug screening | Tu, Ting-Yuan; Wang, Zhe; Bai, Jing; Sun, Wei; Peng, Weng Kung; RUBY YUN-JU HUANG ; Thiery, Jean-Paul; Kamm, Roger D | Advanced healthcare materials | 75 | 66 | |
99 | 2014 | Epithelial-mesenchymal transition spectrum quantification and its efficacy in deciphering survival and drug responses of cancer patients | Tan T.Z.; Miow Q.H.; Miki Y.; Noda T.; Mori S.; RUBY YUN-JU HUANG ; Thiery J.P. | EMBO Molecular Medicine | 481 | 455 | |
100 | 2014 | Grainyhead-like 2 regulates molecular subtype switching in epithelial ovarian cancer | Chung, VY; Wong, MK; Kuay, KT; Tan, TZ; Guccione, E; Thiery, JP; RUBY YUN-JU HUANG | CANCER RESEARCH | 0 | 0 | |
101 | 2014 | Modeling of cancer metastasis and drug resistance via biomimetic nano-cilia and microfluidics | Kuo, C.-T.; Chiang, C.-L.; Chang, C.-H.; Liu, H.-K.; Huang, G.-S.; RUBY YUN-JU HUANG ; Lee, H.; CHIUN-SHENG HUANG ; HSIN-YU LEE ; ANDREW WO | Biomaterials | 58 | 52 | |
102 | 2014 | Lgr5 marks stem/progenitor cells in ovary and tubal epithelia | Ng A.; Tan S.; Singh G.; Rizk P.; Swathi Y.; Tan T.Z.; RUBY YUN-JU HUANG ; Leushacke M.; Barker N. | Nature Cell Biology | 168 | 157 | |
103 | 2014 | A spatiotemporally defined in vitro microenvironment for controllable signal delivery and drug screening | Kuo, C.-T.; Liu, H.-K.; Huang, G.-S.; Chang, C.-H.; Chen, C.-L.; Chen, K.-C.; RUBY YUN-JU HUANG ; CHING-HUNG LIN ; Lee, H.; CHIUN-SHENG HUANG ; ANDREW WO | Analyst | 16 | 14 | |
104 | 2013 | Screening therapeutic EMT blocking agents in a three-dimensional microenvironment | Aref A.R.; RUBY YUN-JU HUANG ; Yu W.; Chua K.-N.; Sun W.; Tu T.-Y.; Bai J.; Sim W.-J.; Zervantonakis I.K.; Thiery J.P.; Kamm R.D. | Integrative Biology (United Kingdom) | 139 | 126 | |
105 | 2013 | Functional genomics identifies five distinct molecular subtypes with clinical relevance and pathways for growth control in epithelial ovarian cancer | Tan T.Z.; Miow Q.H.; RUBY YUN-JU HUANG ; Wong M.K.; Ye J.; Lau J.A.; Wu M.C.; Bin Abdul Hadi L.H.; Soong R.; Choolani M.; Davidson B.; Nesland J.M.; Wang L.-Z.; Matsumura N.; Mandai M.; Konishi I.; Goh B.-C.; Chang J.T.; Thiery J.P.; Mori S. | EMBO Molecular Medicine | 159 | 151 | |
106 | 2013 | An EMT spectrum defines an anoikis-resistant and spheroidogenic intermediate mesenchymal state that is sensitive to e-cadherin restoration by a src-kinase inhibitor, saracatinib (AZD0530) | RUBY YUN-JU HUANG ; Wong M.K.; Tan T.Z.; Kuay K.T.; C Ng A.H.; Chung V.Y.; Chu Y.-S.; Matsumura N.; Lai H.-C.; Lee Y.F.; Sim W.-J.; Chai C.; Pietschmann E.; Mori S.; Low J.J.H.; Choolani M.; Thiery J.P. | Cell Death and Disease | 316 | 290 | |
107 | 2012 | Microscale culture and enrichment of cancer stem cells for drug development | Kuo C.-T.; Chiang C.-L.; Wu C.-T.; Huang G.-S.; RUBY YUN-JU HUANG ; Lee H.; Wo A.M. | Proceedings of the 16th International Conference on Miniaturized Systems for Chemistry and Life Sciences, MicroTAS 2012 | 0 | ||
108 | 2012 | Lysophosphatidic acid modulates the association of PTP1B with N-cadherin/catenin complex in SKOV3 ovarian cancer cells | RUBY YUN-JU HUANG ; Wen C.-C.; Liao C.-K.; SHU-HUEI WANG ; Chou L.-Y.; Wu J.-C. | Cell Biology International | 10 | 8 | |
109 | 2012 | 95 Identification of EMTed Carcinoma and Potential Therapeutic Strategies | Thiery, J.; Sim, W.J.; Ng, A.; Chua, K.; RUBY YUN-JU HUANG ; Mori, S.; Tan, T.; Pierga, J.Y.; Bidart, F.C. | European Journal of Cancer | 0 | 0 | |
110 | 2012 | Epithelial-mesenchymal gene expression signature defines clinically relevant subtypes in epithelial ovarian cancer | RUBY YUN-JU HUANG ; Tan, TZ; Wong, MK; Matsumura, N; Lai, HC; Chung, VY; Ye, J; Mori, S; Thiery, JP | CANCER RESEARCH | 0 | 1 | |
111 | 2012 | Gene expression analysis of matched ovarian primary tumors and peritoneal metastasis | Malek J.A.; Martinez A.; Mery E.; Ferron G.; RUBY YUN-JU HUANG ; Raynaud C.; Jouve E.; Thiery J.-P.; Querleu D.; Rafii A. | Journal of Translational Medicine | 20 | 18 | |
112 | 2012 | Targeting pathways contributing to epithelial-mesenchymal transition (EMT) in epithelial ovarian cancer | RUBY YUN-JU HUANG ; Chung V.Y.; Thiery J.P. | Current Drug Targets | 66 | 64 | |
113 | 2012 | Genetic alterations of the metastatic lesions in ovarian carcinoma | Malek, J; Mery, E; George, B; Martinez, A; Thiery, JP; RUBY YUN-JU HUANG ; Querleu, D; Rafii, A | CANCER RESEARCH | 0 | 0 | |
114 | 2012 | Early events in cell adhesion and polarity during epithelialmesenchymal transition | RUBY YUN-JU HUANG ; Guilford P.; Thiery J.P. | Journal of Cell Science | 266 | 247 | |
115 | 2012 | Histotype-specific copy-number alterations in ovarian cancer. | RUBY YUN-JU HUANG ; Chen G.B.; Matsumura N.; Lai H.C.; Mori S.; Li J.; Wong M.K.; Konishi I.; Thiery J.P.; Goh L. | BMC medical genomics | 36 | 33 | |
116 | 2012 | Configurable 2D and 3D spheroid tissue cultures on bioengineered surfaces with acquisition of epithelial-mesenchymal transition characteristics | HSIN-YU LEE ; Chiang, C.-L.; RUBY YUN-JU HUANG ; Lee, H.; ANDREW WO | NPG Asia Materials | 44 | 43 | |
117 | 2011 | Rapid microwell prototyping, generation of 3D multicellular cancer aggregates, and emt drug screening | Tu T.-Y.; Sun W.; Peng W.K.; Wang Z.; RUBY YUN-JU HUANG ; Matsudaira P.T.; Thiery J.-P.; Kamm R.D. | 15th International Conference on Miniaturized Systems for Chemistry and Life Sciences 2011, MicroTAS 2011 | 0 | ||
118 | 2011 | Target cell movement in tumor and cardiovascular diseases based on the epithelial-mesenchymal transition concept | Chua K.-N.; Poon K.L.; Lim J.; Sim W.-J.; RUBY YUN-JU HUANG ; Thiery J.P. | Advanced Drug Delivery Reviews | 39 | 37 | |
119 | 2011 | Epithelial-mesenchymal transition spectrum characterized by an ovarian cancer cell line library defines an aggressive metastable state | RUBY YUN-JU HUANG ; Wong, MK; Chung, VY; Ng, A; Lee, YF; Pietschmann, E; Mori, S; Matsumura, N; Thiery, JP | CANCER RESEARCH | 0 | 0 | |
120 | 2011 | Probing the tratis of epithelial-mesenchymal transition in a microfluidic device | Kuo C.T.; Chiang C.L.; RUBY YUN-JU HUANG ; Lee H.; Wo A.M. | 15th International Conference on Miniaturized Systems for Chemistry and Life Sciences 2011, MicroTAS 2011 | 3 | ||
121 | 2011 | Epithelial-mesenchymal transition as a mechanism for the progression of breast carcinoma | Thiery, JP; Sim, WJ; Chua, K; RUBY YUN-JU HUANG ; Mori, S; Tan, T; Bidart, FC; Pierga, JY | BREAST CANCER RESEARCH | 0 | 2 | |
122 | 2011 | Copy number variation analysis of matched ovarian primary tumors and peritoneal metastasis | Malek J.A.; Mery E.; Mahmoud Y.A.; Al-Azwani E.K.; Roger L.; RUBY YUN-JU HUANG ; Jouve E.; Lis R.; Thiery J.-P.; Querleu D.; Rafii A. | PLoS ONE | 42 | 38 | |
123 | 2010 | Epithelial mesenchymal transition during development in fibrosis and in the progression of carcinoma | Thiery J.-P.; Chua, K; Sim, Wen Jing; RUBY YUN-JU HUANG | Bulletin du cancer | 28 | 26 | |
124 | 2010 | Identification of genomic alterations of human serous ovarian carcinoma with genome-wide integration of copy number and gene expression analysis | RUBY YUN-JU HUANG ; Davidson, B.; Kuznetsov, V.; Hsieh, C. Y.; Thiery, J. P. | Annual meeting of the American Association for Cancer Research, proceedings | |||
125 | 2010 | Identification of genomic alterations of human serous ovarian carcinoma with genome-wide integration of copy number and gene expression analysis | RUBY YUN-JU HUANG ; Davidson, B; Kuznetsov, V; Hsieh, CY; Thiery, JP | CANCER RESEARCH | 0 | 0 | |
126 | 2010 | Transitions between epithelial and mesenchymal states in microfluidic platform: Acquisition of malignant and stem cell traits | Aref A.R.; RUBY YUN-JU HUANG ; Kang W.; Jing S.W.; Thiery J.P.; Kamm R.D. | Nanotechnology 2010: Electronics, Devices, Fabrication, MEMS, Fluidics and Computational - Technical Proceedings of the 2010 NSTI Nanotechnology Conference and Expo, NSTI-Nanotech 2010 | 0 | ||
127 | 2009 | O392 Identification of genomic alterations of human ovarian carcinoma with genome-wide copy number analysis | RUBY YUN-JU HUANG ; Davidson, B.; Kuznetsov, V.; Hsieh, C.; Thiery, J. | International Journal of Gynecology & Obstetrics | 0 | 0 | |
128 | 2009 | Identification of Genomic Alterations in Ovarian Carcinoma by Using Integrative Genomics Analysis Platforms | RUBY YUN-JU HUANG | ||||
129 | 2009 | Epithelial-Mesenchymal Transitions in Development and Disease | Thiery J.P.; Acloque H.; RUBY YUN-JU HUANG ; Nieto M.A. | Cell | 8118 | 7672 | |
130 | 2008 | Lysophosphatidic acid induces ovarian cancer cell dispersal by activating Fyn kinase associated with p120-catenin | RUBY YUN-JU HUANG ; Wang S.-M.; CHANG-YAO HSIEH ; Wu J.-C. | International Journal of Cancer | 24 | 22 | |
131 | 2007 | Molecular profiling of EGF-induced epithelial-mesenchymal transition of human ovarian surface epithelial cells | Ozbun, L.; RUBY YUN-JU HUANG ; Salamanca, C.; Auersperg, N.; Birrer, M. | Annual meeting of the American Association for Cancer Research, proceedings. | |||
132 | 2007 | Signaling profiles of EGF-induced epithelial-mesenchymal transition of human ovarian surface epithelial cells | RUBY YUN-JU HUANG ; Choi, J. H.; Salamanca, C.; Pelech, S.; Ozbun, L.; Birrer, M.; Auersperg, N. | Annual meeting of the American Association for Cancer Research, proceedings | |||
133 | 2005 | Up-regulation of interleukin-6 in human ovarian cancer cell via a Gi/PI3K-Akt/NF-κB pathway by lysophosphatidic acid, an ovarian cancer-activating factor | Chou C.-H; LING-HUNG WEI ; Kuo M.-L; RUBY YUN-JU HUANG ; Lai K.-P; CHI-AN CHEN ; CHANG-YAO HSIEH | Carcinogenesis | 78 | 74 | |
134 | 2005 | Linking epithelial-mesenchymal transition to the well-known polarity protein par6 | Thiery J.P.; RUBY YUN-JU HUANG | Developmental Cell | 28 | 29 | |
135 | 2005 | Arsenic trioxide prevents radiation-enhanced tumor invasiveness and inhibits matrix metalloproteinase-9 through downregulation of nuclear factor κB | LING-HUNG WEI ; Lai K.-P.; CHI-AN CHEN ; CHIA-HSIEN CHENG ; RUBY YUN-JU HUANG ; Chou C.-H.; Kuo M.-L.; CHANG-YAO HSIEH | Oncogene | 62 | 58 | |
136 | 2004 | Clinical Presentation of Pelvic Tuberculosis Imitating Ovarian Malignancy | RUBY YUN-JU HUANG ; LING-HUNG WEI ; CHANG-YAO HSIEH | Taiwanese Journal of Obstetrics and Gynecology | 8 | 0 | |
137 | 2004 | Pure-type clear cell carcinoma of the ovary as a distinct histological type and improved survival in patients treated with paclitaxel-platinum-based chemotherapy in pure-type advanced disease | Ho C.-M.; RUBY YUN-JU HUANG ; Chen T.-C.; Huang S.-H.; Liu F.-S.; Chang Chien C.-C.; Yu M.-H.; TSUI-LIEN MAO ; Wang T.-Y.; CHANG-YAO HSIEH | Gynecologic Oncology | 94 | 93 |